vs

Side-by-side financial comparison of Enact Holdings, Inc. (ACT) and CONMED Corp (CNMD). Click either name above to swap in a different company.

CONMED Corp is the larger business by last-quarter revenue ($317.0M vs $312.7M, roughly 1.0× Enact Holdings, Inc.). On growth, Enact Holdings, Inc. posted the faster year-over-year revenue change (3.6% vs -1.3%). Over the past eight quarters, Enact Holdings, Inc.'s revenue compounded faster (3.6% CAGR vs -2.3%).

Enact Holdings, Inc. is a leading U.S.-based private mortgage insurance provider. It delivers risk mitigation solutions to residential mortgage lenders, banks, and credit unions, enabling borrowers with smaller down payments to access affordable home financing, and supports sustainable homeownership for diverse consumer groups across the United States.

The CONMED Corporation is a publicly traded American manufacturer of medical equipment and surgical devices, primarily in the orthopedic, laparoscopic and general surgery, and patient care areas. CONMED's headquarters is in Largo, Florida. Prior to July 2022, it was in Utica, New York. CONMED embraces a people-first culture that starts with a mission to support their healthcare partners and the patients they serve. They have manufacturing facilities in the United States and Mexico, offices in...

ACT vs CNMD — Head-to-Head

Bigger by revenue
CNMD
CNMD
1.0× larger
CNMD
$317.0M
$312.7M
ACT
Growing faster (revenue YoY)
ACT
ACT
+4.9% gap
ACT
3.6%
-1.3%
CNMD
Faster 2-yr revenue CAGR
ACT
ACT
Annualised
ACT
3.6%
-2.3%
CNMD

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ACT
ACT
CNMD
CNMD
Revenue
$312.7M
$317.0M
Net Profit
$13.8M
Gross Margin
57.9%
Operating Margin
71.3%
8.0%
Net Margin
4.4%
Revenue YoY
3.6%
-1.3%
Net Profit YoY
129.1%
EPS (diluted)
$1.23
$0.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACT
ACT
CNMD
CNMD
Q1 26
$317.0M
Q4 25
$312.7M
$373.2M
Q3 25
$311.5M
$337.9M
Q2 25
$304.9M
$342.3M
Q1 25
$306.8M
$321.3M
Q4 24
$301.8M
$345.9M
Q3 24
$309.6M
$316.7M
Q2 24
$298.8M
$332.1M
Net Profit
ACT
ACT
CNMD
CNMD
Q1 26
$13.8M
Q4 25
Q3 25
$2.9M
Q2 25
$21.4M
Q1 25
$6.0M
Q4 24
Q3 24
$49.0M
Q2 24
$30.0M
Gross Margin
ACT
ACT
CNMD
CNMD
Q1 26
57.9%
Q4 25
58.5%
Q3 25
49.2%
Q2 25
55.0%
Q1 25
55.3%
Q4 24
57.3%
Q3 24
56.5%
Q2 24
55.3%
Operating Margin
ACT
ACT
CNMD
CNMD
Q1 26
8.0%
Q4 25
71.3%
9.8%
Q3 25
67.4%
3.5%
Q2 25
70.4%
11.1%
Q1 25
68.9%
5.0%
Q4 24
68.9%
15.2%
Q3 24
74.1%
20.7%
Q2 24
78.6%
14.2%
Net Margin
ACT
ACT
CNMD
CNMD
Q1 26
4.4%
Q4 25
Q3 25
0.8%
Q2 25
6.3%
Q1 25
1.9%
Q4 24
Q3 24
15.5%
Q2 24
9.0%
EPS (diluted)
ACT
ACT
CNMD
CNMD
Q1 26
$0.45
Q4 25
$1.23
$0.54
Q3 25
$1.10
$0.09
Q2 25
$1.11
$0.69
Q1 25
$1.08
$0.19
Q4 24
$1.05
$1.09
Q3 24
$1.15
$1.57
Q2 24
$1.16
$0.96

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACT
ACT
CNMD
CNMD
Cash + ST InvestmentsLiquidity on hand
$582.5M
Total DebtLower is stronger
$744.5M
Stockholders' EquityBook value
$5.4B
Total Assets
$6.9B
Debt / EquityLower = less leverage
0.14×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACT
ACT
CNMD
CNMD
Q1 26
Q4 25
$582.5M
Q3 25
$545.6M
Q2 25
$616.0M
Q1 25
$639.0M
Q4 24
$602.8M
Q3 24
$674.9M
Q2 24
$711.3M
Total Debt
ACT
ACT
CNMD
CNMD
Q1 26
Q4 25
$744.5M
$834.2M
Q3 25
$744.1M
$853.0M
Q2 25
$743.8M
$881.1M
Q1 25
$743.4M
$891.4M
Q4 24
$743.0M
$905.1M
Q3 24
$742.7M
$940.1M
Q2 24
$742.4M
$965.2M
Stockholders' Equity
ACT
ACT
CNMD
CNMD
Q1 26
Q4 25
$5.4B
$1.0B
Q3 25
$5.3B
$1.0B
Q2 25
$5.2B
$1.0B
Q1 25
$5.1B
$977.6M
Q4 24
$5.0B
$962.7M
Q3 24
$5.0B
$932.9M
Q2 24
$4.8B
$881.8M
Total Assets
ACT
ACT
CNMD
CNMD
Q1 26
Q4 25
$6.9B
$2.3B
Q3 25
$6.9B
$2.3B
Q2 25
$6.8B
$2.3B
Q1 25
$6.7B
$2.3B
Q4 24
$6.5B
$2.3B
Q3 24
$6.6B
$2.3B
Q2 24
$6.3B
$2.3B
Debt / Equity
ACT
ACT
CNMD
CNMD
Q1 26
Q4 25
0.14×
0.81×
Q3 25
0.14×
0.85×
Q2 25
0.14×
0.88×
Q1 25
0.15×
0.91×
Q4 24
0.15×
0.94×
Q3 24
0.15×
1.01×
Q2 24
0.15×
1.09×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACT
ACT
CNMD
CNMD
Operating Cash FlowLast quarter
$724.5M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACT
ACT
CNMD
CNMD
Q1 26
Q4 25
$724.5M
$46.3M
Q3 25
$192.0M
$53.7M
Q2 25
$119.5M
$29.1M
Q1 25
$226.7M
$41.5M
Q4 24
$686.3M
$43.3M
Q3 24
$188.1M
$51.2M
Q2 24
$144.7M
$43.3M
Free Cash Flow
ACT
ACT
CNMD
CNMD
Q1 26
Q4 25
$41.2M
Q3 25
$48.5M
Q2 25
$23.4M
Q1 25
$37.8M
Q4 24
$39.3M
Q3 24
$47.8M
Q2 24
$39.7M
FCF Margin
ACT
ACT
CNMD
CNMD
Q1 26
Q4 25
11.0%
Q3 25
14.4%
Q2 25
6.8%
Q1 25
11.8%
Q4 24
11.4%
Q3 24
15.1%
Q2 24
12.0%
Capex Intensity
ACT
ACT
CNMD
CNMD
Q1 26
Q4 25
1.4%
Q3 25
1.5%
Q2 25
1.7%
Q1 25
1.2%
Q4 24
1.2%
Q3 24
1.1%
Q2 24
1.1%
Cash Conversion
ACT
ACT
CNMD
CNMD
Q1 26
Q4 25
Q3 25
18.78×
Q2 25
1.36×
Q1 25
6.88×
Q4 24
Q3 24
1.05×
Q2 24
1.44×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons